MedTech Dive July 28, 2025
Olympus and Revival Healthcare Capital agreed to invest up to $458 million combined to co-found a company that will develop a robotic platform for gastrointestinal treatment.
Dive Brief:
- Olympus said Friday it is partnering with Revival Healthcare Capital to develop a robotic system initially focused on gastrointestinal treatments.
- Tokyo-based Olympus and Austin, Texas-based Revival have agreed to found Swan EndoSurgical and will jointly invest up to $458 million to develop the robotic platform. Revival said it is taking a majority equity stake in the startup, and the structured investment gives Olympus an option to acquire Swan.
- Medtech trade group AdvaMed said the unique deal between two of its members — co-founding a third company to develop a specific medical...
Today's Sponsors
Today's Sponsor